A Pharmacokinetic Study of Sugammadex in Dialysis Patients
Status:
Withdrawn
Trial end date:
2021-09-10
Target enrollment:
Participant gender:
Summary
The primary objective of this prospective study is to assess the trend of sugammadex (and its
complex with rocuronium) concentration in surgical patients with routine outpatient
hemodialysis. Patients with end stage renal disease who are to receive general anesthesia and
muscle paralysis will have their paralysis by rocuronium reversed with sugammadex. Patients
will then have blood drawn during their next three routine hemodialysis sessions to assess
for the plasma concentration of sugammadex or the sugammadex-rocuronium complex over time.